Lion’s Mane vs Alpha-GPC (2026): What the Human Trials Show

Affiliate links: as an Amazon Associate and through other programs, we earn from qualifying purchases, at no extra cost to you. Learn more.

Reviewed October 202610 min readEvidence-basedBy Víctor, founder · How we work

Quick answer: Lion’s mane is an edible mushroom: in small trials, older adults with mild cognitive impairment or early Alzheimer’s disease who took about 1 to 3 g a day for 16 to 49 weeks scored better than with placebo (Mori et al., 2009; Li et al., 2020), while trials in healthy young adults were mostly null (Grozier et al., 2022; Surendran et al., 2025). Alpha-GPC is a choline compound with few, short trials in healthy adults, and an observational study of 12 million Korean adults aged 50 or older linked its use to a 43% higher 10-year stroke risk (Lee et al., 2021). We found no trial that compared the two.

What Lion’s Mane and Alpha-GPC Are

Lion’s mane (Hericium erinaceus) is an edible mushroom. In laboratory work, a lion’s mane extract raised nerve growth factor (NGF) in human astrocytoma cells, a type of brain tumor cell, and in the brains of mice; in the same study, three of its compounds called hericenones did not (Mori et al., 2008). Those are lab results, not proof of an effect in people.

Lion's mane supplements compared: powder vs extract (2026)

ProductOn the labelGood to knowBuy
NOW Lion's Mane 500 mg1,000 mg organic lion's mane mushroom powder per 2 capsulesWhole mushroom powder: the label gives no extract ratio or compound levels.See it on Amazon ↗
Real Mushrooms Lion's Mane1,000 mg organic lion's mane extract per 2 capsules, with 300 mg beta-glucansAn extract with its beta-glucan content stated on the label.See it on Amazon ↗
Host Defense Lion's Mane1 g organic lion's mane per 2 capsulesThe label in the NIH database lists no extract ratio.See it on Amazon ↗

Human evidence is still limited: the best-known trial had 30 people (Mori 2009).

Label figures: NIH Dietary Supplement Label Database and the brand listing, checked October 2026. Formulas change, so check the label before you buy. We earn a commission on Amazon purchases at no extra cost to you, and we do not lab-test products.

Alpha-GPC (L-alpha-glycerylphosphorylcholine, also called choline alfoscerate) is a choline-containing compound used by many adults over 50 because it may act as a building block for acetylcholine, a brain messenger (Lee et al., 2021). It was first authorized in 1985, and countries still differ on whether it is a prescription medicine (Sagaro et al., 2023).

🆕 Free Download

Get our free supplement cheat sheet.

One page: typical doses, timing and upper limits for ten well-studied supplements. No upsell.

🔒 No spam. Unsubscribe anytime. We send 1-2 emails/month max.

So the two are not alternatives in the usual sense: one is a mushroom tested mainly over months, the other a choline compound tested both as a single dose and as a long-term medicine. We found no trial that compared them head to head, and the sections below cover each one separately.

Lion’s Mane: What the Human Trials Found

TrialWho and how manyDose and lengthWhat happened
Mori et al., 200930 Japanese adults aged 50 to 80 with mild cognitive impairment3 g a day of dried mushroom powder (four 250 mg tablets three times a day) for 16 weeksCognitive scores rose more than with placebo at weeks 8, 12 and 16, then fell 4 weeks after stopping
Saitsu et al., 2019Adults in a placebo-controlled trial of fruiting-body supplements12 weeksMini-Mental State Examination scores improved; two other memory tests did not differ
Li et al., 2020People with mild Alzheimer’s diseaseThree 350 mg capsules a day of a mycelium extract rich in erinacine A for 49 weeksMini-Mental State scores improved with the extract while another cognitive score fell on placebo; 4 people dropped out
Docherty et al., 202341 healthy adults aged 18 to 451.8 g a day; a single dose and 28 daysFaster on one attention test 60 minutes after the first dose; a trend toward less stress at 28 days; other results null
Grozier et al., 202224 college-age adults (single-blind)10 g a day in muffins for 4 weeksNo effect on cognition
Surendran et al., 202518 healthy adults aged 18 to 35 (crossover)One 3 g dose of a 10:1 fruiting-body extractNo overall effect on cognition or mood; better on one dexterity test

Who paid matters here. The first author of the 2009 trial worked at a mushroom company (Mori et al., 2009); the company that makes the extract in the 2020 trial paid five of its ten authors and supplied research materials (Li et al., 2020); the 2023 trial used a product donated by its seller (Docherty et al., 2023); and two authors of the 2025 study worked for a drinks company that uses lion’s mane (Surendran et al., 2025). A 2025 systematic review found only five randomized trials (Menon et al., 2025).

Alpha-GPC: What the Human Trials Found

TrialWho and how manyDose and lengthWhat happened
De Jesus Moreno Moreno, 2003261 people aged 60 to 80 with mild to moderate Alzheimer’s dementia400 mg three times a day (1,200 mg) for 180 daysCognitive scores improved compared with placebo
Jeon et al., 2024100 adults with mild cognitive impairment600 mg a day for 12 weeksA cognitive score (ADAS-cog) improved by 2.34 points, significantly more than with placebo; the capsule maker paid for the trial
Kerksick, 202420 resistance-trained men (crossover)One dose of 315 mg or 630 mgBetter Stroop test scores 60 minutes after the dose; no change on two other cognitive tests, physical performance or growth hormone
Tamura et al., 202139 healthy volunteers (single-blind)400 mg at bedtime for 2 weeksHigher evening motivation scores; no effect on anxiety
Bellar et al., 201513 college-age men (crossover)600 mg a day for 6 daysMore lower-body force than placebo; upper-body force did not differ significantly
Marcus et al., 201748 college-age men250 mg or 500 mg a day for 7 daysNo differences in strength or vigilance; one jump measure improved most at 250 mg

The single-dose study was sponsored by an alpha-GPC maker, and its author was the company’s paid scientific adviser (Kerksick, 2024). Both exercise studies used capsules from an alpha-GPC maker (Bellar et al., 2015; Marcus et al., 2017). In 36 older adults with type 2 diabetes and mild cognitive decline, 1,200 mg a day for 12 months improved Mini-Mental State scores by 1.7 points more than placebo, in a trial funded by a drug company (Sohn et al., 2025). A 2023 review of 7 trials and 1 cohort study found that alpha-GPC, alone or with the dementia drug donepezil, improved cognition in conditions linked to injury of the brain’s blood vessels (Sagaro et al., 2023).

Which One Fits Which Goal

Because no trial has compared them, any choice rests on separate studies with different people, doses and lengths.

  • A short-term boost before a task: neither has strong evidence. Single doses of alpha-GPC (Kerksick, 2024) and of lion’s mane (Docherty et al., 2023) each improved one attention test, while a single 3 g dose of a lion’s mane extract had no overall effect (Surendran et al., 2025).
  • Memory in older age: the trials of both were in people with mild cognitive impairment or Alzheimer’s disease (Mori et al., 2009; De Jesus Moreno Moreno, 2003; Jeon et al., 2024). If you notice memory changes, see a doctor first.
  • Exercise performance: alpha-GPC has two short, small trials from the same research group, with mixed results (Bellar et al., 2015; Marcus et al., 2017); lion’s mane did not change exercise metabolism or cognition in a 4-week trial in college-age adults (Grozier et al., 2022).
  • If you have heart disease or stroke risk factors: read the alpha-GPC safety section below before considering it.

Taking Them Together

We found no trial that tested lion’s mane and alpha-GPC together, so there is no evidence that the pair adds up to more than either one alone. If you combine them anyway, check every product you take for alpha-GPC or choline, and tell your doctor, especially if you take blood thinners or have stroke risk factors (see the safety section below).

Doses Used in the Trials

These are study doses, not personal advice. For the full evidence on each, see our lion’s mane guide and our alpha-GPC guide.

Safety: What to Know Before Taking Either

Lion’s mane

In the 49-week trial, 4 people dropped out because of abdominal discomfort, nausea or a skin rash (Li et al., 2020), and a 2025 review lists stomach discomfort, headache and allergic reactions as possible side effects (Menon et al., 2025). In laboratory tests, a lion’s mane compound called hericenone B blocked platelet clumping in rabbit and human platelets (Mori et al., 2010), so ask your doctor first if you take blood thinners.

Alpha-GPC and stroke

In a study of 12 million South Korean adults aged 50 and older, people prescribed alpha-GPC had a 43% higher risk of stroke over about 10 years than matched non-users, and the risk rose with longer use (Lee et al., 2021). The authors noted that choline has been linked to heart disease through trimethylamine-N-oxide (TMAO), a compound made by gut bacteria, and in mice prone to clogged arteries, alpha-GPC sped up atherosclerosis (Wang et al., 2021). A later Korean study of 508,107 people with mild cognitive impairment found the opposite pattern: users were less likely to progress to dementia, and stroke risk was lower in those who did not progress (Kim et al., 2025).

Both are observational studies of prescription records, so neither can prove cause and effect. Until better data exist, people with heart disease, stroke risk factors or a past stroke should talk to their doctor before taking alpha-GPC. In one 7-day trial, 500 mg a day also lowered TSH, the pituitary hormone that controls the thyroid (Marcus et al., 2017).

Lion’s Mane vs Alpha-GPC: Common Questions

Is lion’s mane or alpha-GPC better for focus?

No trial has compared them. Single doses of each improved one attention test in small trials, while other tests and studies showed no effect.

How long does lion’s mane take to work?

The trials that found benefits in older adults ran 16 to 49 weeks. In the 16-week trial, the gains faded within 4 weeks of stopping.

Is alpha-GPC safe?

Short trials reported few side effects, but a study of 12 million Korean adults aged 50 or older linked alpha-GPC prescriptions to a higher 10-year stroke risk, while a later study of people with mild cognitive impairment linked it to a lower risk of dementia. Talk to your doctor first if you have heart disease or stroke risk factors.

Can I take lion’s mane and alpha-GPC together?

No trial has tested the combination, so its effects are unknown. If you combine them, tell your doctor, especially if you take blood thinners.

What doses did the trials use?

Lion’s mane trials used about 1 to 3 g a day; alpha-GPC trials used 250 to 630 mg in healthy adults and up to 1,200 mg a day in people with memory disorders.

The Bottom Line on Lion’s Mane vs Alpha-GPC

Neither supplement has strong evidence for focus in healthy adults. Lion’s mane has a few small trials, with benefits mainly in older adults with memory problems and several trials tied to companies that sell it (Mori et al., 2009; Li et al., 2020). Alpha-GPC has more trials as a dementia medicine and two observational studies that disagree about stroke (Lee et al., 2021; Kim et al., 2025). If you try either one, use a dose from the trials, give it time, and talk to your doctor first if you have heart disease or stroke risk factors.

Looking for the right brand?

See which lion’s mane products we picked and what their labels say.

See Best Lion’s Mane Supplements 2026 →

Scientific References

  1. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res. Mori et al., 2009
  2. Prevention of Early Alzheimer’s Disease by Erinacine A-Enriched Hericium erinaceus Mycelia Pilot Double-Blind Placebo-Controlled Study. Front Aging Neurosci. Li et al., 2020
  3. Four Weeks of Hericium erinaceus Supplementation Does Not Impact Markers of Metabolic Flexibility or Cognition. Int J Exerc Sci. Grozier et al., 2022
  4. Acute effects of a standardised extract of Hericium erinaceus (Lion’s Mane mushroom) on cognition and mood in healthy younger adults: a double-blind randomised placebo-controlled study. Front Nutr. Surendran et al., 2025
  5. Association of L-α Glycerylphosphorylcholine With Subsequent Stroke Risk After 10 Years. JAMA Netw Open. Lee et al., 2021
  6. Nerve growth factor-inducing activity of Hericium erinaceus in 1321N1 human astrocytoma cells. Biol Pharm Bull. Mori et al., 2008
  7. Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis. J Alzheimers Dis. Sagaro et al., 2023
  8. Improvement of cognitive functions by oral intake of Hericium erinaceus. Biomed Res. Saitsu et al., 2019
  9. The Acute and Chronic Effects of Lion’s Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study. Nutrients. Docherty et al., 2023
  10. Benefits, side effects, and uses of Hericium erinaceus as a supplement: a systematic review. Front Nutr. Menon et al., 2025
  11. Cognitive improvement in mild to moderate Alzheimer’s dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial. Clin Ther. De Jesus Moreno Moreno, 2003
  12. Efficacy and safety of choline alphoscerate for amnestic mild cognitive impairment: a randomized double-blind placebo-controlled trial. BMC Geriatr. Jeon et al., 2024
  13. Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men. Nutrients. Kerksick, 2024
  14. Alpha-Glycerylphosphorylcholine Increases Motivation in Healthy Volunteers: A Single-Blind, Randomized, Placebo-Controlled Human Study. Nutrients. Tamura et al., 2021
  15. The effect of 6 days of alpha glycerylphosphorylcholine on isometric strength. J Int Soc Sports Nutr. Bellar et al., 2015
  16. Evaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performance. J Int Soc Sports Nutr. Marcus et al., 2017
  17. Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial. Diabetes Obes Metab. Sohn et al., 2025
  18. Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation. Phytomedicine. Mori et al., 2010
  19. The Nutritional Supplement L-Alpha Glycerylphosphorylcholine Promotes Atherosclerosis. Int J Mol Sci. Wang et al., 2021
  20. Association between L-α glycerylphosphorylcholine use and delayed dementia conversion: A nationwide longitudinal study in South Korea. J Prev Alzheimers Dis. Kim et al., 2025